Assisted Reproduction: Highlights From the American Society for Reproductive Medicine Annual Meeting

Peter Kovacs, MD


November 04, 2003

In This Article


The 59th annual meeting of ASRM, held in San Antonio, Texas, October 11-15, was attended by a few thousand physicians and nurses from all over the world. Oral and poster presentations were accepted from 28 countries. Last year, many presentations dealt with the gonadotropin need of the growing follicle and with changes to ovarian stimulation protocols based on our increased understanding of folliculogenesis; this year, preimplantation genetic diagnosis (PGD) was the hot topic. PGD has become an integral part of reproductive medicine as a result of improved technology and recent advances in the field of human genetics. Morning conferences, plenary sessions, and numerous oral and poster presentations were dedicated to the discussion of PDG as part of assisted reproduction.

Polycystic ovary syndrome (PCOS), and the management of patients with PCOS, has been a challenge for healthcare providers.. Novel treatment options are being developed and evaluated as we learn more about the pathogenesis of PCOS, and some of these were discussed at ASRM.

Another challenge for the clinician involved with infertility treatment and assisted reproduction is the management of poor responder patients during controlled ovarian hyperstimulation. Minor changes in stimulation protocols and the incorporation of new drugs are aimed at improving the pregnancy rates of poor responders. Several presentations were dedicated to the discussion of various protocols for poor responders. The following report will discuss these topics and some further interesting presentations.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.